ARTICLE | Company News
Nile Therapeutics, Medtronic deal
March 7, 2011 8:00 AM UTC
Medtronic will fund Nile's Phase I trial to evaluate cenderitide (formerly CD-NP) delivered through Medtronic's diabetes pump technology to treat heart failure. Nile expects to start the trial next ...